By Chiara Holzhaeuser and Antonis Pothitos
(Reuters) -Shares in Clariant fell 7.5% on Tuesday after the Swiss speciality chemicals maker lowered its full-year sales forecast due to a weak performance in its catalysts unit, overshadowing a hike in its margin target.
Clariant expects its sales to be flat or grow by up to a low single-digit percentage this year. Growth in its Adsorbents & Additives unit and its Care Chemicals arm, which includes the newly acquired Lucas Meyer, is expected to compensate for uncertainties in the catalyst business, it said.
The group had originally guided for low single-digit percent sales growth in local currency.
“Investors probably didn’t like the weak performance of the catalyst business and the lowered sales guidance,” Kepler Cheuvreux analyst Christian Faitz said.
Sales in the catalysts division, which provides catalytic solutions for the chemical industry, fell by 18% in local currency to 222 million Swiss francs ($250.5 million) in the second quarter, hit by declines across its segments.
Clariant said the unit’s volumes fell from a year earlier “due to the project nature of the business”, while pricing remained stable.
While Clariant expects the overall inflationary environment to continue to ease, it said it does not anticipate a broad market recovery in the second half of the year.
“Our expectation moving forward is for raw materials (prices) to slightly sequentially increase,” CEO Conrad Keijzer said during a conference call. For the whole year, raw material costs should still be 7% lower than in 2023, he added.
The company raised its 2024 core profit (EBITDA) margin forecast to around 16% from around 15% previously.
Its EBITDA margin rose to 16.4% in the first half of the year, aided by lower raw material and energy costs and a reduced impact from the closing of its Sunliquid bioethanol production in Romania.
($1 = 0.8861 Swiss francs)
(Reporting by Chiara Holzhaeuser and Antonis Pothitos in Gdansk; Editing by Milla Nissi)
